Novartis chief sees sales dip until mid-2013
Swiss pharmaceutical giant Novartis said Sunday the expiry of a US patent for its leading hypertension drug Diovan caused a drop in turnover that could last into the first half of 2013.
Medications
Oct 07, 2012 |
not rated yet |
0
India's patent laws under pressure: The Lancet special report
In a special report in The Lancet, researchers from Queen Mary, University of London (UK) argue that pending cases against India's patent laws threaten public health and misinterpret international intellectual property agreem ...
Medications
Sep 10, 2012 |
not rated yet |
0
EU approves Novartis-Incyte blood cancer drug
Novartis AG and Incyte Corp. said Tuesday that European Union regulators approved their blood cancer drug Jakavi.
Medications
Sep 04, 2012 |
not rated yet |
0
Afinitor disperz approved for rare pediatric cancer
(HealthDay)—The U.S. Food and Drug Administration has approved Afinitor Disperz (everolimus tablets for oral suspension), the first form of the anti-cancer drug Afinitor to be created especially for children.
Medications
Aug 29, 2012 |
not rated yet |
0
Researchers test new drug for patients with neuroendocrine tumors
A researcher at Moffitt Cancer Center and his international team of colleagues have reported study results on a novel multireceptor-targeted somatostatin analogue called pasireotide (SOM230) manufactured by Novartis Pharma ...
Cancer
Aug 06, 2012 |
not rated yet |
0
New drugs shore up Novartis in Q2
(AP) — Swiss pharmaceutical company Novartis AG reported a net profit of $2.73 billion during the second quarter, as new drugs and acquisitions offset patent expirations, lower sales of generic medicines ...
Other
Jul 19, 2012 |
not rated yet |
0
Computer model successfully predicts drug side effects
A new set of computer models has successfully predicted negative side effects in hundreds of current drugs, based on the similarity between their chemical structures and those molecules known to cause side effects, according ...
Medical research
Jun 11, 2012 |
5 / 5 (2) |
0
|
Greek crisis creates medicine shortages
Greece's highly uncertain future has forced businesses into a quasi hand-to-mouth existence, with one of the most alarming effects a shortage of medicines, including for the seriously ill.
Medications
Jun 06, 2012 |
not rated yet |
0
EU approves Novartis drug Signifor for Cushing's disease
European Union regulators have given Swiss pharmaceutical group Novartis a green light to market its drug Signifor as a treatment for Cushing's disease, the company said Wednesday.
Medications
Apr 25, 2012 |
5 / 5 (1) |
0
Novartis tries to make UK hospitals use $1000 drug
(AP) -- Drug maker Novartis says it is taking legal action in Britain to make hospitals use an eye drug that costs 700 pounds ($1,130) per shot instead of a cheaper one that costs 60 pounds ($97).
Medications
Apr 24, 2012 |
1 / 5 (1) |
0
Research team finds compound that can spur cartilage growth
(Medical Xpress) -- A research team from drug maker Novartis has discovered a compound that spurs cartilage growth in mice. As they describe in their paper published in the journal Science, the team has found that when a ...
Medical research
Apr 06, 2012 |
5 / 5 (5) |
0
|
Novartis says EU approves expanded use of Glivec
Swiss pharmaceutical group Novartis said Monday the European Union will allow it to expand its use of the drug Glivec to treat certain rare forms of gastrointestinal cancer.
Medications
Feb 27, 2012 |
not rated yet |
0
Delivery of child-friendly antimalarial hits the 100 million mark
One hundred million treatments of Coartem Dispersible (artemether-lumefantrine), an antimalarial developed especially for children with Plasmodium falciparum malaria, have been delivered by Novartis to 39 malaria-endemic ...
Diseases, Conditions, Syndromes
Feb 22, 2012 |
5 / 5 (1) |
0
Vaccine discovered for hep C
(Medical Xpress) -- A University of Alberta researcher and Canada Excellence Research Chair in Virology has made the discovery of a vaccine that will potentially help combat hepatitis C. Michael Houghton, ...
Diseases, Conditions, Syndromes
Feb 16, 2012 |
5 / 5 (17) |
0
|
Drug firms sign up to new tropical disease fight
Key players in the pharmaceutical industry pledged on Monday to donate 14 billion drug treatments as part of a new, global push to eradicate tropical diseases.
Diseases, Conditions, Syndromes
Jan 30, 2012 |
not rated yet |
0
